{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:45:10Z","timestamp":1747205110405,"version":"3.40.5"},"posted":{"date-parts":[[2024,3,13]]},"group-title":"In Review","reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,2,22]]},"abstract":"<title>Abstract<\/title>\n        <p>The goal of any vaccine is to induce long-lived plasma cells (LLPC) to provide life-long protection. Natural infection by influenza, measles, or mumps viruses generates bone marrow (BM) LLPC similar to tetanus vaccination which affords safeguards for decades. Although the SARS-CoV-2 mRNA vaccines protect from severe disease, the serologic half-life is short-lived even though SARS-CoV-2-specific plasma cells can be found in the BM. To better understand this paradox, we enrolled 19 healthy adults at 1.5-33 months after SARS-CoV-2 mRNA vaccine and measured influenza-, tetanus-, or SARS-CoV-2-specific antibody secreting cells (ASC) in LLPC (CD19<sup>-<\/sup>) and non-LLPC (CD19<sup>+<\/sup>) subsets within the BM. All individuals had IgG ASC specific for influenza, tetanus, and SARS-CoV-2 in at least one BM ASC compartment. However, only influenza- and tetanus-specific ASC were readily detected in the LLPC whereas SARS-CoV-2 specificities were mostly excluded. The ratios of non-LLPC:LLPC for influenza, tetanus, and SARS-CoV-2 were 0.61, 0.44, and 29.07, respectively. Even in five patients with known PCR-proven history of infection and vaccination, SARS-CoV-2-specific ASC were mostly excluded from the LLPC. These specificities were further validated by using multiplex bead binding assays of secreted antibodies in the supernatants of cultured ASC. Similarly, the IgG ratios of non-LLPC:LLPC for influenza, tetanus, and SARS-CoV-2 were 0.66, 0.44, and 23.26, respectively. In all, our studies demonstrate that rapid waning of serum antibodies is accounted for by the inability of mRNA vaccines to induce BM LLPC.<\/p>","DOI":"10.21203\/rs.3.rs-3979237\/v1","type":"posted-content","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T16:18:21Z","timestamp":1710346701000},"source":"Crossref","is-referenced-by-count":0,"title":["The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-5942","authenticated-orcid":false,"given":"Frances","family":"Lee","sequence":"first","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-6731","authenticated-orcid":false,"given":"Doan","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Hentenaar","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Morrison-Porter","sequence":"additional","affiliation":[{"name":"Emory"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Solano","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-3094","authenticated-orcid":false,"given":"Natalie","family":"Haddad","sequence":"additional","affiliation":[{"name":"MicroB-plex"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Castrillon","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9262-2920","authenticated-orcid":false,"given":"Pedro","family":"Lamothe","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Andrews","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Roberts","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Lonial","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4182-587X","authenticated-orcid":false,"given":"Ignacio","family":"Sanz","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO. https:\/\/covid19.who.int.Accessed12\/06\/2023 (2023)."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.13115","article-title":"COVID-19 and plasma cells: Is there long-lived protection?","volume":"309","author":"Nguyen DC","year":"2022","unstructured":"Nguyen, D. C. et al. COVID-19 and plasma cells: Is there long-lived protection? Immunol Rev 309, 40\u201363, doi:10.1111\/imr.13115 (2022).","journal-title":"Immunol Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.immuni.2022.05.004","article-title":"Instructing durable humoral immunity for COVID-19 and other vaccinable diseases","volume":"55","author":"Bhattacharya D","year":"2022","unstructured":"Bhattacharya, D. Instructing durable humoral immunity for COVID-19 and other vaccinable diseases. Immunity 55, 945\u2013964, doi:10.1016\/j.immuni.2022.05.004 (2022).","journal-title":"Immunity"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad353","article-title":"SARS-CoV-2 Hybrid Immunity: The Best of Both Worlds","author":"Lasrado N","year":"2023","unstructured":"Lasrado, N. & Barouch, D. H. SARS-CoV-2 Hybrid Immunity: The Best of Both Worlds. J Infect Dis, doi:10.1093\/infdis\/jiad353 (2023).","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.13013","article-title":"Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators","volume":"303","author":"Nguyen DC","year":"2021","unstructured":"Nguyen, D. C. et al. Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators. Immunol Rev 303, 138\u2013153, doi:10.1111\/imr.13013 (2021).","journal-title":"Immunol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03647-4","article-title":"SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans","author":"Turner JS","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature, doi:10.1038\/s41586-021-03647-4 (2021).","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","article-title":"Germinal centre-driven maturation of B cell response to mRNA vaccination","volume":"604","author":"Kim W","year":"2022","unstructured":"Kim, W. et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature 604, 141\u2013145, doi:10.1038\/s41586-022-04527-1 (2022).","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"eadd5960","DOI":"10.1126\/scitranslmed.add5960","article-title":"Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates","volume":"16","author":"Prabhakaran M","year":"2024","unstructured":"Prabhakaran, M. et al. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates. Sci Transl Med 16, eadd5960, doi:10.1126\/scitranslmed.add5960 (2024).","journal-title":"Sci Transl Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.immuni.2015.06.016","article-title":"Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow","volume":"43","author":"Halliley JL","year":"2015","unstructured":"Halliley, J. L. et al. Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow. Immunity 43, 132\u2013145, doi:10.1016\/j.immuni.2015.06.016 (2015).","journal-title":"Immunity"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101285","article-title":"Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting","volume":"5","author":"Joyner CJ","year":"2022","unstructured":"Joyner, C. J. et al. Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting. Life Sci Alliance 5, doi:10.26508\/lsa.202101285 (2022).","journal-title":"Life Sci Alliance"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"112682","DOI":"10.1016\/j.celrep.2023.112682","article-title":"Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses","volume":"42","author":"Duan M","year":"2023","unstructured":"Duan, M. et al. Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. Cell Rep 42, 112682, doi:10.1016\/j.celrep.2023.112682 (2023).","journal-title":"Cell Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/s41590-022-01345-5","article-title":"Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota","volume":"23","author":"Liu X","year":"2022","unstructured":"Liu, X., Yao, J., Zhao, Y., Wang, J. & Qi, H. Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota. Nat Immunol 23, 1564\u20131576, doi:10.1038\/s41590-022-01345-5 (2022).","journal-title":"Nat Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.04.015","author":"Robinson MJ","year":"2023","unstructured":"Robinson, M. J. et al. Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan. Immunity 56, 1596\u20131612 e1594, doi:10.1016\/j.immuni.2023.04.015 (2023)."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/blood-2014-02-555169","article-title":"A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow","volume":"125","author":"Mei HE","year":"2015","unstructured":"Mei, H. E. et al. A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow. Blood 125, 1739\u20131748, doi:10.1182\/blood-2014-02-555169 (2015).","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1038\/s41467-018-05853-7","article-title":"Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion","volume":"9","author":"Nguyen DC","year":"2018","unstructured":"Nguyen, D. C. et al. Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion. Nat Commun 9, 3698, doi:10.1038\/s41467-018-05853-7 (2018).","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.3389\/fimmu.2019.02138","article-title":"Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells","volume":"10","author":"Nguyen DC","year":"2019","unstructured":"Nguyen, D. C., Joyner, C. J., Sanz, I. & Lee, F. E. Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells. Front Immunol 10, 2138, doi:10.3389\/fimmu.2019.02138 (2019).","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41590-022-01340-w","article-title":"The secret to longevity, plasma cell style","volume":"23","author":"Tellier J","year":"2022","unstructured":"Tellier, J. & Nutt, S. L. The secret to longevity, plasma cell style. Nat Immunol 23, 1507\u20131508, doi:10.1038\/s41590-022-01340-w (2022).","journal-title":"Nat Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna IJ","year":"2007","unstructured":"Amanna, I. J., Carlson, N. E. & Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357, 1903\u20131915, doi:10.1056\/NEJMoa066092 (2007).","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer F","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol 19, 383\u2013397, doi:10.1038\/s41577-019-0143-6 (2019).","journal-title":"Nat Rev Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature07231","article-title":"Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors","volume":"455","author":"Yu X","year":"2008","unstructured":"Yu, X. et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455, 532\u2013536, doi:10.1038\/nature07231 (2008).","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1086\/587643","article-title":"Safety and immunogenicity of trivalent inactivated influenza vaccine in infants","volume":"197","author":"Halasa NB","year":"2008","unstructured":"Halasa, N. B., Gerber, M. A., Chen, Q., Wright, P. F. & Edwards, K. M. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 197, 1448\u20131454, doi:10.1086\/587643 (2008).","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1128\/CVI.00396-10","article-title":"Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands","volume":"18","author":"Bodewes R","year":"2011","unstructured":"Bodewes, R. et al. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol 18, 469\u2013476, doi:10.1128\/CVI.00396-10 (2011).","journal-title":"Clin Vaccine Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e1002082","DOI":"10.1371\/journal.pbio.1002082","article-title":"Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data","volume":"13","author":"Kucharski AJ","year":"2015","unstructured":"Kucharski, A. J. et al. Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data. PLoS Biol 13, e1002082, doi:10.1371\/journal.pbio.1002082 (2015).","journal-title":"PLoS Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock K","year":"2009","unstructured":"Hancock, K. et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361, 1945\u20131952, doi:10.1056\/NEJMoa0906453 (2009).","journal-title":"N Engl J Med"},{"key":"ref25","first-page":"521","article-title":"C. f. D. C. a. P. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine","volume":"58","author":"(CDC)","year":"2009","unstructured":"(CDC), C. f. D. C. a. P. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58, 521\u2013524 (2009).","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.4049\/jimmunol.1000091","article-title":"Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus","volume":"185","author":"Skountzou I","year":"2010","unstructured":"Skountzou, I. et al. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 185, 1642\u20131649, doi:10.4049\/jimmunol.1000091 (2010).","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1056\/NEJMc0907256","article-title":"Older age and a reduced likelihood of 2009 H1N1 virus infection","volume":"361","author":"Fisman DN","year":"2009","unstructured":"Fisman, D. N. et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 361, 2000\u20132001, doi:10.1056\/NEJMc0907256 (2009).","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ni.3684","article-title":"Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins","volume":"18","author":"Nachbagauer R","year":"2017","unstructured":"Nachbagauer, R. et al. Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins. Nat Immunol 18, 464\u2013473, doi:10.1038\/ni.3684 (2017).","journal-title":"Nat Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert J","year":"2008","unstructured":"Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667\u2013671, doi:10.1038\/nature06890 (2008).","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.4049\/jimmunol.1002932","article-title":"Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect","volume":"186","author":"Lee FE","year":"2011","unstructured":"Lee, F. E. et al. Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J Immunol 186, 5514\u20135521, doi:10.4049\/jimmunol.1002932 (2011).","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp D","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263, doi:doi:10.1126\/science.abb2507 (2020).","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1182\/blood-2004-07-2507","article-title":"Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response","volume":"105","author":"Odendahl M","year":"2005","unstructured":"Odendahl, M. et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105, 1614\u20131621, doi:10.1182\/blood-2004-07-2507 (2005).","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4049\/immunohorizons.2100011","article-title":"One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses","volume":"5","author":"Haddad NS","year":"2021","unstructured":"Haddad, N. S. et al. One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses. Immunohorizons 5, 322\u2013335, doi:10.4049\/immunohorizons.2100011 (2021).","journal-title":"Immunohorizons"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ni.3348","article-title":"Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response","volume":"17","author":"Tellier J","year":"2016","unstructured":"Tellier, J. et al. Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response. Nat Immunol 17, 323\u2013330, doi:10.1038\/ni.3348 (2016).","journal-title":"Nat Immunol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/ni.2524","article-title":"Plasma cells require autophagy for sustainable immunoglobulin production","volume":"14","author":"Pengo N","year":"2013","unstructured":"Pengo, N. et al. Plasma cells require autophagy for sustainable immunoglobulin production. Nat Immunol 14, 298\u2013305, doi:10.1038\/ni.2524 (2013).","journal-title":"Nat Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.07.084","author":"Lam WY","year":"2018","unstructured":"Lam, W. Y. et al. Metabolic and Transcriptional Modules Independently Diversify Plasma Cell Lifespan and Function. Cell Rep 24, 2479\u20132492 e2476, doi:10.1016\/j.celrep.2018.07.084 (2018)."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3389\/fimmu.2019.01787","article-title":"Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination","volume":"10","author":"Palm AE","year":"2019","unstructured":"Palm, A. E. & Henry, C. Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination. Front Immunol 10, 1787, doi:10.3389\/fimmu.2019.01787 (2019).","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.03.001","author":"Nellore A","year":"2023","unstructured":"Nellore, A. et al. A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans. Immunity 56, 847\u2013863 e848, doi:10.1016\/j.immuni.2023.03.001 (2023)."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad603","article-title":"Deficient Generation of Spike-Specific Long-Lived Plasma Cells in the Bone Marrow After Severe Acute Respiratory Syndrome Coronavirus 2 Infection","author":"Tehrani ZR","year":"2024","unstructured":"Tehrani, Z. R. et al. Deficient Generation of Spike-Specific Long-Lived Plasma Cells in the Bone Marrow After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis, doi:10.1093\/infdis\/jiad603 (2024).","journal-title":"J Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"104735","DOI":"10.1016\/j.ebiom.2023.104735","article-title":"SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow","volume":"95","author":"Schulz AR","year":"2023","unstructured":"Schulz, A. R. et al. SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow. EBioMedicine 95, 104735, doi:10.1016\/j.ebiom.2023.104735 (2023).","journal-title":"EBioMedicine"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"101726","DOI":"10.1016\/j.trim.2022.101726","article-title":"Bone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture","volume":"75","author":"Mujtahedi SS","year":"2022","unstructured":"Mujtahedi, S. S. et al. Bone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture. Transpl Immunol 75, 101726, doi:10.1016\/j.trim.2022.101726 (2022).","journal-title":"Transpl Immunol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bcmd.2003.12.001","article-title":"Normal and malignant human plasma cells: proliferation, differentiation, and expansions in relation to CD45 expression","volume":"32","author":"Pellat-Deceunynck C","year":"2004","unstructured":"Pellat-Deceunynck, C. & Bataille, R. Normal and malignant human plasma cells: proliferation, differentiation, and expansions in relation to CD45 expression. Blood Cells Mol Dis 32, 293\u2013301, doi:10.1016\/j.bcmd.2003.12.001 (2004).","journal-title":"Blood Cells Mol Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"108572","DOI":"10.1016\/j.isci.2023.108572","article-title":"mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection","volume":"26","author":"Ivanova EN","year":"2023","unstructured":"Ivanova, E. N. et al. mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection. iScience 26, 108572, doi:10.1016\/j.isci.2023.108572 (2023).","journal-title":"iScience"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/eji.201040649","article-title":"Interferon-alpha induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZBxNZW)F1 mice but not in BALB\/c mice","volume":"41","author":"Mathian A","year":"2011","unstructured":"Mathian, A., Gallegos, M., Pascual, V., Banchereau, J. & Koutouzov, S. Interferon-alpha induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZBxNZW)F1 mice but not in BALB\/c mice. Eur J Immunol 41, 863\u2013872, doi:10.1002\/eji.201040649 (2011).","journal-title":"Eur J Immunol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(03)00208-5","author":"Jego G","year":"2003","unstructured":"Jego, G. et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225\u2013234, doi:10.1016\/s1074-7613(03)00208-5 (2003)."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41541-020-00264-6","article-title":"SARS-CoV-2 structural features may explain limited neutralizing-antibody responses","volume":"6","author":"Bachmann MF","year":"2021","unstructured":"Bachmann, M. F., Mohsen, M. O., Zha, L., Vogel, M. & Speiser, D. E. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses. NPJ Vaccines 6, 2, doi:10.1038\/s41541-020-00264-6 (2021).","journal-title":"NPJ Vaccines"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3389\/fimmu.2019.00956","article-title":"Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses","volume":"10","author":"Slifka MK","year":"2019","unstructured":"Slifka, M. K. & Amanna, I. J. Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses. Front Immunol 10, 956, doi:10.3389\/fimmu.2019.00956 (2019).","journal-title":"Front Immunol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41592-022-01450-1","article-title":"Response under pressure: deploying emerging technologies to understand B-cell-mediated immunity in COVID-19","volume":"19","author":"Woodruff MC","year":"2022","unstructured":"Woodruff, M. C. et al. Response under pressure: deploying emerging technologies to understand B-cell-mediated immunity in COVID-19. Nat Methods 19, 387\u2013391, doi:10.1038\/s41592-022-01450-1 (2022).","journal-title":"Nat Methods"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e0293203","DOI":"10.1371\/journal.pone.0293203","article-title":"Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease","volume":"18","author":"Haddad NS","year":"2023","unstructured":"Haddad, N. S. et al. Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease. PLoS One 18, e0293203, doi:10.1371\/journal.pone.0293203 (2023).","journal-title":"PLoS One"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3979237\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3979237\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T07:11:53Z","timestamp":1727507513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3979237\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":49,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3979237\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41591-024-03278-y","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,3,13]]},"subtype":"preprint"}}